MediPal Holdings Corporation (TYO:7459)

Market Cap	482.21B
Revenue (ttm)	3.67T
Net Income (ttm)	40.28B
Shares Out	206.87M
EPS (ttm)	193.19
PE Ratio	12.07
Forward PE	13.40
Dividend	64.00 (2.74%)
Ex-Dividend Date	Mar 28, 2025

Volume	173,500
Average Volume	397,395
Open	2,319.00
Previous Close	2,331.00
Day's Range	2,309.00 - 2,330.00
52-Week Range	2,156.00 - 2,770.00
Beta	0.00
RSI	49.62
Earnings Date	Aug 5, 2025

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for comp...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,075
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7459

Financial Performance

In 2024, MediPal Holdings's revenue was 3.67 trillion, an increase of 3.16% compared to the previous year's 3.56 trillion. Earnings were 40.28 billion, a decrease of -2.88%.